Ruthenium Complexes with PNN Pincer Ligands Based on (Chiral) Pyrrolidines:Synthesis, Structure, and Dynamic Stereochemistry

We report the synthesis of lutidine-based PNN type metal pincer complexes, using achiral (pyrrolidine) as well as chiral ((R,R)-2,5-dimethylpyrrolidine and (R)-2-methylpyrrolidine) substituents at the N side arm of the pincer ligand. With the six-coordinate saturated Ru pincers (PNN)Ru(H)(CO)(Cl), which have an aromatic pyridine ligand backbone, as the starting materials, treatment with strong base (KOtBu) generated the corresponding dearomatized pincer complexes (PNN′)Ru(H)(CO). Spectroscopic, crystallographic, and computational studies demonstrate that the C-centered chirality from the chiral pyrrolidine group exerts a small but non-negligible influence on the preferred stereochemistry at Ru (and N in the case of (R)-2-methylpyrrolidine) that is reflected in the equilibrium distribution of diastereomers of these Ru complexes in solution. Our data show that the N- and Ru-based stereogenic centers in this class of compounds are stereochemically labile and the mechanisms for epimerization are discussed. Inversion at the Ru center in the dearomatized complexes is proposed to occur via a rearomatized Ru(0) intermediate in which the Ru-bound hydride is transferred to the ligand. Support for this comes from the spectroscopic characterization of a closely related Ru(0) species that is obtained by reaction with CO. Testing these catalysts in enantioselective oxa-Michael addition or transfer hydrogenation led to racemic products, while a low ee (8%) was observed in the hydrogenation of 4-fluoroacetophenone. The lack of appreciable enantioinduction with these catalysts is ascribed to the kinetic lability of the Ru stereocenter, which results in the formation of equilibrium mixtures in which several diastereomers of the catalyst are present.</p

Photoactive Fe Catalyst for Light-Triggered Alkyd Paint Curing

[Image: see text] Herein, we show that the photoactive complexes [(Cp)Fe(arene)](+) (Cp = cyclopentadienyl; arene = C(6)H(6), C(6)H(5)Me) act as latent catalysts that allow for photochemical control over the onset of alkyd paint curing, without the need for antiskinning agents such as the volatile 2-butanone oxime normally used to prevent curing during paint storage. The highly soluble neutral complexes [(Cp)Fe(Ch)] and [(Cp)Fe(Ch′)] (Ch = cyclohexadienyl, Ch′ = methylcyclohexadienyl) readily convert to the photoactive complexes [(Cp)Fe(arene)](+) upon oxidation in alkyd, allowing the latter to be dosed in a wide range of concentrations. Infrared and Raman studies show similar spectral changes of the alkyd paint matrix as have been observed in alkyd curing mediated by well-known, industrially applied cobalt- and manganese-based catalyst Co(neodecanoate)(2) and [(Me(3)TACN)(2)Mn(2)(μ-OOCR)(3)](OOCR). The [(Cp)Fe(Ch)]/[(Cp)Fe(arene)](+) system performs equally well as these cobalt- and manganese-based catalysts in terms of drying time and outperform the manganese catalyst by showing a hardness development (increase) similar to that of the cobalt-based catalyst. Based on electron paramagnetic resonance and light–activity studies, we propose that photolysis of [(Cp)Fe(arene)](+) generates short-lived active Fe(II) species, explaining the desired latency. The [(Cp)Fe(Ch)]/[(Cp)Fe(arene)](+) alkyd curing systems presented herein are unique examples of intrinsically latent paint curing catalysts that (1) are based on an abundant and harmless transition metal (Fe), (2) do not require any antiskinning agents, and (3) show favorable performance in terms of drying times and hardness development

Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review

OBJECTIVE: To determine the influence of ethnic differences in diabetes care on inequalities in mortality and prevalence of end-stage complications among diabetic patients. The following questions were examined: 1) Are there ethnic differences among diabetic patients in mortality and end-stage complications and 2) are there ethnic differences among diabetic patients in quality of care? RESEARCH DESIGN AND METHODS: A review of the literature on ethnic differences in the prevalence of complications and mortality among diabetic patients and in the quality of diabetes care was performed by systematically searching articles on Medline published from 1987 through October 2004. RESULTS: A total of 51 studies were included, mainly conducted in the U.S. and the U.K. In general, after adjusting for confounders, diabetic patients from ethnic minorities had higher mortality rates and higher risk of diabetes complications. After additional adjustment for risk factors such as smoking, socioeconomic status, income, years of education, and BMI, in most instances ethnic differences disappear. Nevertheless, blacks and Hispanics in the U.S. and Asians in the U.K. have an increased risk of end-stage renal disease, and blacks and Hispanics in the U.S. have an increased risk of retinopathy. Intermediate outcomes of care were worse in blacks, and they were inclined to be worse in Hispanics. Likewise, ethnic differences in quality of care in the U.S. exist: process of care was worse in blacks. CONCLUSIONS: Given the fact that there are ethnic differences in diabetes care and that ethnic differences in some diabetes complications persist after adjustment for risk factors other than diabetes care, it seems the case that ethnic differences in diabetes care contribute to the more adverse disease outcomes of diabetic patients from some ethnic minority groups. Although no generalizations can be made for all ethnic groups in all regions for all kinds of complications, the results do implicate the importance of quality of care in striving for equal health outcomes among ethnic minoriti

Mouse model for the DNA repair/basal transcription disorder Trichothiodystrophy reveals cancer predisposition.

Patients with the nucleotide excision repair (NER) disorder xeroderma pigmentosum (XP) are highly predisposed to develop sunlight-induced skin cancer, in remarkable contrast to photosensitive NER-deficient trichothiodystrophy (TTD) patients carrying mutations in the same XPD gene. XPD encodes a helicase subunit of the dually functional DNA repair/basal transcription complex TFIIH. The pleiotropic disease phenotype is hypothesized to be, in part, derived from a repair defect causing UV sensitivity and, in part, from a subtle, viable basal transcription deficiency accounting for the cutaneous, developmental, and the typical brittle hair features of TTD. To understand the relationship between deficient NER and tumor susceptibility, we used a mouse model for TTD that mimics an XPD point mutation of a TTD patient in the mouse germline. Like the fibroblasts from the patient, mouse cells exhibit a partial NER defect, evident from the reduced UV-induced DNA repair synthesis (residual repair capacity approximately 25%), limited recovery of RNA synthesis after UV exposure, and a relatively mild hypersensitivity to cell killing by UV or 7,12-dimethylbenz[a]anthracene. In accordance with the cellular studies, TTD mice exhibit a modestly increased sensitivity to UV-induced inflammation and hyperplasia of the skin. In striking contrast to the human syndrome, TTD mice manifest a dear susceptibility to UV- and 7,12-dimethylbenz[a]anthracene-induced skin carcinogenesis, albeit not as pronounced as the totally NER-deficient XPA mice. These findings open up the possibility that TTD is associated with a so far unnoticed cancer predisposition and support the notion that a NER deficiency enhances cancer susceptibility. These findings have important implications for the etiology of the human disorder and for the impact of NER on carcinogenesis

Ethnic differences in Internal Medicine referrals and diagnosis in the Netherlands

As in other Western countries, the number of immigrants in the Netherlands is growing rapidly. In 1980 non-western immigrants constituted about 3% of the population, in 1990 it was 6% and currently it is more than 10%. Nearly half of the migrant population lives in the four major cities. In the municipality of Rotterdam 34% of the inhabitants are migrants. Health policy is based on the ideal that all inhabitants should have equal access to health care and this requires an efficient planning of health care resources, like staff and required time per patient. The aim of this study is to examine ethnic differences in the use of internal medicine outpatient care, specifically to examine ethnic differences in the reason for referral and diagnosis. Methods We conducted a study with an open cohort design. We registered the ethnicity, sex, age, referral reasons, diagnosis and living area of all ne

Photoactive Fe Catalyst for Light-Triggered Alkyd Paint Curing

Herein, we show that the photoactive complexes [(Cp)Fe(arene)]+ (Cp = cyclopentadienyl; arene = C6H6, C6H5Me) act as latent catalysts that allow for photochemical control over the onset of alkyd paint curing, without the need for antiskinning agents such as the volatile 2-butanone oxime normally used to prevent curing during paint storage. The highly soluble neutral complexes [(Cp)Fe(Ch)] and [(Cp)Fe(Ch′)] (Ch = cyclohexadienyl, Ch′ = methylcyclohexadienyl) readily convert to the photoactive complexes [(Cp)Fe(arene)]+ upon oxidation in alkyd, allowing the latter to be dosed in a wide range of concentrations. Infrared and Raman studies show similar spectral changes of the alkyd paint matrix as have been observed in alkyd curing mediated by well-known, industrially applied cobalt- and manganese-based catalyst Co(neodecanoate)2 and [(Me3TACN)2Mn2(μ-OOCR)3](OOCR). The [(Cp)Fe(Ch)]/[(Cp)Fe(arene)]+ system performs equally well as these cobalt- and manganese-based catalysts in terms of drying time and outperform the manganese catalyst by showing a hardness development (increase) similar to that of the cobalt-based catalyst. Based on electron paramagnetic resonance and light–activity studies, we propose that photolysis of [(Cp)Fe(arene)]+ generates short-lived active FeII species, explaining the desired latency. The [(Cp)Fe(Ch)]/[(Cp)Fe(arene)]+ alkyd curing systems presented herein are unique examples of intrinsically latent paint curing catalysts that (1) are based on an abundant and harmless transition metal (Fe), (2) do not require any antiskinning agents, and (3) show favorable performance in terms of drying times and hardness development

A Photolabile Fe Catalyst for Light-Triggered Alkyd Paint Curing

In search for cobalt replacements for alkyd paint curing we show that the photo-active complex [(Cp)Fe(C6H6)]+ (Cp = cyclopentadienyl) acts as a latent catalytic drier that allows for photochemical control over the onset of curing, without the need for anti-skinning agents such as the volatile MEKO normally used to prevent curing during paint storage. The highly soluble neutral complex [(Cp)Fe(Ch)] (Ch = cyclohexadienyl) readily converts to the photo-active complex [(Cp)Fe(C6H6)]+ upon oxidation in alkyd, allowing the latter to be dosed in a wide range of concentrations. Infrared and Raman studies show similar spectral changes of the alkyd paint matrix as have been observed in alkyd curing mediated by the known commercial cobalt- and manganese-based driers Durham NUODEX® Cobalt 10 Neo and NUODEX® DryCoat. The new [(Cp)Fe(Ch)] / [(Cp)Fe(C6H6)]+ system performs equally well as both commercial paint driers in terms of drying time, and outperforms NUODEX® DryCoat by showing a hardness development (increase) similar to the cobalt-based drier. Based on an observed light-dark on/off effect and EPR studies we propose that photolysis of [(Cp)Fe(C6H6)]+ generates short-lived active FeII species, explaining the excellent latency. The novel alkyd curing system [(Cp)Fe(Ch)] / [(Cp)Fe(C6H6)]+ presented herein is the first example of an intrinsically latent paint curing catalyst that is: (1) based on an abundant and harmless transition metal (Fe), (2) doesn’t require any anti-skinning agents, and (3) shows excellent performance in terms of drying times and hardness development. <br /